Recombinant probiotic bacteria
US10738315B2 · kind B2 · utility
0Cited by
5References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2015 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | Nov 2, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to recombinant probiotic bacteria, especially for use in the treatment of an inflammatory skin dysfunction, as well as a method for treating an inflammatory skin dysfunction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.